# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009812
Filing Date
2023-03-30
Accepted
2023-03-30 17:01:09
Documents
77
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1499751
2 |  | ex3-5.htm | EX-3.5 | 1993
3 |  | ex4-3.htm | EX-4.3 | 27632
4 |  | ex23-1.htm | EX-23.1 | 3178
5 |  | ex31-1.htm | EX-31.1 | 19556
6 |  | ex31-2.htm | EX-31.2 | 19430
7 |  | ex32-1.htm | EX-32.1 | 5743
8 |  | ex32-2.htm | EX-32.2 | 5764
9 |  | form10-k_001.jpg | GRAPHIC | 11739
10 |  | form10-k_002.jpg | GRAPHIC | 7982
11 |  | form10-k_003.jpg | GRAPHIC | 20530
12 |  | form10-k_004.jpg | GRAPHIC | 15100
13 |  | form10-k_005.jpg | GRAPHIC | 21507
14 |  | ex3-5_001.jpg | GRAPHIC | 198738
15 |  | ex3-5_002.jpg | GRAPHIC | 423058
| Complete submission text file | 0001493152-23-009812.txt |  | 7176886

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
16 | XBRL SCHEMA FILE | gtbp-20221231.xsd | EX-101.SCH | 55853
17 | XBRL CALCULATION FILE | gtbp-20221231_cal.xml | EX-101.CAL | 51503
18 | XBRL DEFINITION FILE | gtbp-20221231_def.xml | EX-101.DEF | 185808
19 | XBRL LABEL FILE | gtbp-20221231_lab.xml | EX-101.LAB | 430131
20 | XBRL PRESENTATION FILE | gtbp-20221231_pre.xml | EX-101.PRE | 298991
71 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 737174

Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40023 | Film No.: 23781544
SIC: 2834 Pharmaceutical Preparations